Skip to content. | Skip to navigation

Personal tools

Sections

Tutelles

logo Inserm      logo cnrslogo ENSL       logo ucb1

 

logo ENSL       logo ucb1

 

 

 

You are here: Home / Teams / Vanhems P - PHE3ID / Publications

Publications

Publications 2022

1. Assembling a global database of child pneumonia studies to inform WHO pneumonia management algorithm: Methodology and applications. Martin H, Falconer J, Addo-Yobo E, Aneja S, Arroyo LM, Asghar R, Awasthi S, Banajeh S, Bari A, Basnet S, Bavdekar A, Bhandari N, Bhatnagar S, Bhutta ZA, Brooks A, Chadha M, Chisaka N, Chou M, Clara AW, Colbourn T, Cutland C, D'Acremont V, Echavarria M, Gentile A, Gessner B, Gregory CJ, Hazir T, Hibberd PL, Hirve S, Hooli S, Iqbal I, Jeena P, Kartasasmita CB, King C, Libster R, Lodha R, Lozano JM, Lucero M, Lufesi N, MacLeod WB, Madhi SA, Mathew JL, Maulen-Radovan I, McCollum ED, Mino G, Mwansambo C, Neuman MI, Nguyen NTV, Nunes MC, Nymadawa P, O'Grady KF, Pape JW, Paranhos-Baccala G, Patel A, Picot VS, Rakoto-Andrianarivelo M, Rasmussen Z, Rouzier V, Russomando G, Ruvinsky RO, Sadruddin S, Saha SK, Santosham M, Singhi S, Soofi S, Strand TA, Sylla M, Thamthitiwat S, Thea DM, Turner C, Vanhems P, Wadhwa N, Wang J, Zaman SM, Campbell H, Nair H, Qazi SA, Nisar YB; World Health Organization Pneumonia Research Partnership to Assess WHO Recommendation (PREPARE) study group. J Glob Health. 2022;12:04075.

2. Factors associated with the nutritional status of children under 5 years of age in Guinea between 2005 and 2018. Bangoura ST, Rabilloud M, Camara A, Campoy S, Condé M, Vanhems P, Kadio KJO, Touré A, Khanafer N. Public Health Nutr. 2022:1-23.

3. Predicted Impacts of Booster, Immunity Decline, Vaccination Strategies, and Non-Pharmaceutical Interventions on COVID-19 Outcomes in France.Pageaud S, Eyraud-Loisel A, Bertoglio JP, Bienvenüe A, Leboisne N, Pothier C, Rigotti C, Ponthus N, Gauchon R, Gueyffier F, Vanhems P, Iwaz J, Loisel S, Roy P, On Behalf Of The CovDyn Group Covid Dynamics.Vaccines (Basel). 2022;10(12):2033.

4. Further Cautions When Modeling the Public Health Impact of Infectious Diseases. Vanhems P, Nunes MC. Am J Public Health. 2022 ;112(11):e1-e2. 

5. Using ELEFIGHT® QR Codes for Quick Access to Information on Influenza Burden and Prevention: A Pilot Study in Lyon University Hospital. N. Khanafer, S. Oudot, C. Planckaert, N. Paquin, C. Mena, N. Trehet Mandel, R. Chapurlat, C. Lombard, G. Martin-Gaujard, L. Juillard, C. Elias, A. Janoly-Dumenil, A. Jolivot, M. Benazzouz, M. Maligeay, MP. Ayala, D. Ismail, P. Vanhems. Vaccines 2022, 10, 1591.

6. Bacterial Cross-Transmission between Inanimate Surfaces and Patients in Intensive Care Units under Real-World Conditions: A Repeated Cross-Sectional Study. Kuczewski E, Henaff L, Regard A, Argaud L, Lukaszewicz AC, Rimmelé T, Cassier P, Fredenucci I, Loeffert-Frémiot S, Khanafer N, Vanhems P. Int J Environ Res Public Health. 2022;19(15):9401.

7. COVID-19 clusters in a teaching hospital during the second wave of the SARS-CoV-2 pandemic in France: a descriptive study and lessons learned for waves to come. Dananché C, Elias C, Guibert N, Gardes S, Barreto C, Denis MA, Fascia P, Gerbier-Colomban S, Grisi B, Khanafer N, Massardier-Pilonchéry A, Munier-Marion É, Pasquet C, Fassier JB, Vanhems P. Am J Infect Control. 2022:S0196-6553(22)00505-3.

8. Protocol for a prospective quasi-experimental study on SARS-CoV-2 transmission during outdoor sports events in France: the COVID-ESO project. Elias C, Nail-Billaud S, Basset P, Laurent F, Dantony E, Fauvernier M, Roy P, Vanhems P. BMJ Open. 2022;12(6):e055927.

9. National influenza surveillance systems in five European countries: a qualitative comparative framework based on WHO guidance. de Fougerolles TR, Damm O, Ansaldi F, Chironna M, Crépey P, de Lusignan S, Gray I, Guillen JM, Kassianos G, Mosnier A, de Lejarazu RO, Pariani E, Puig-Barbera J, Schelling J, Trippi F, Vanhems P, Wahle K, Watkins J, Rasuli A, Vitoux O, Bricout H. BMC Public Health. 2022;22(1):1151.

10. Attributable Mortality of Ventilator-associated Pneumonia Among COVID-19 Patients. Vacheron CH, Lepape A, Savey A, Machut A, Timsit JF, Comparot S, Courno G, Vanhems P, Landel V, Lavigne T, Bailly S, Bettega F, Study Group RR, Maucort-Boulch D, Friggeri A. Am J Respir Crit Care Med. 2022 doi: 10.1164/rccm.202202-0357OC.

11. Vitamin D and COVID-19 Severity in Hospitalized Older Patients: Potential Benefit of Prehospital Vitamin D Supplementation. Parant F, Bouloy J, Haesebaert J, Bendim'red L, Goldet K, Vanhems P, Henaff L, Gilbert T, Cuerq C, Blond E, Bost M, Bonnefoy M. Nutrients. 2022;14(8):1641.

12. Derivation and validation of a novel risk assessment tool to identify children aged 2-59 months at risk of hospitalised pneumonia-related mortality in 20 countries. Rees CA, Colbourn T, Hooli S, King C, Lufesi N, McCollum ED, Mwansambo C, Cutland C, Madhi SA, Nunes M, Matthew JL, Addo-Yobo E, Chisaka N, Hassan M, Hibberd PL, Jeena PM, Lozano JM, MacLeod WB, Patel A, Thea DM, Nguyen NTV, Kartasasmita CB, Lucero M, Awasthi S, Bavdekar A, Chou M, Nymadawa P, Pape JW, Paranhos-Baccala G, Picot VS, Rakoto-Andrianarivelo M, Rouzier V, Russomando G, Sylla M, Vanhems P, Wang J, Asghar R, Banajeh S, Iqbal I, Maulen-Radovan I, Mino-Leon G, Saha SK, Santosham M, Singhi S, Basnet S, Strand TA, Bhatnagar S, Wadhwa N, Lodha R, Aneja S, Clara AW, Campbell H, Nair H, Falconer J, Qazi SA, Nisar YB, Neuman MI; World Health Organization PREPARE study group. BMJ Glob Health. 2022;7(4):e008143

13. Effect of influenza vaccination among healthcare workers on hospital-acquired influenza in short-stay hospitalized patients: A multicenter pilot study in France. Amour S, Bénet T, Regis C, Robert O, Fontana L, Lina B, Pozzetto B, Berthelot P, Vanhems P. Infect Control Hosp Epidemiol. 2022:1-5. doi: 10.1017/ice.2022.68.

14. Undernourished patients do not have increased risk of severe COVID-19 outcomes. Fneich A, Poinsot P, Elias C, Restier L, Vanhems P, Wallet F, Caussy C, Duclos A, Peretti N. Clin Nutr Open Sci. 2022 doi: 10.1016/j.nutos.2022.03.002.

15. T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19. Venet F, Gossez M, Bidar F, Bodinier M, Coudereau R, Lukaszewicz AC, Tardiveau C, Brengel-Pesce K, Cheynet V, Cazalis MA, Pescarmona R, Garnier L, Ortillon M, Buisson M, Bouscambert-Duchamp M, Morfin-Sherpa F, Casalegno JS, Conti F, Rimmelé T, Argaud L, Cour M, Saadatian-Elahi M, Henaff L, Vanhems P, Monneret G; RICO study group. EBioMedicine. 2022;78:103967.

16. A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom. Rigoine de Fougerolles T, Puig-Barbera J, Kassianos G, Vanhems P, Schelling J, Crepey P, de Lejarazu RO, Ansaldi F, Fruhwein M, Galli C, Mosnier A, Pariani E, Rasuli A, Vitoux O, Watkins J, Weinke T, Bricout H. Influenza Other Respir Viruses. 2022;16(3):417-428.

17. Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study. Luque-Paz D, Tattevin P, Loubet P, Bénézit F, Thibault V, Lainé F, Vanhems P, Amour S, Lina B, Duval X, L'Honneur AS, Fidouh N, Vallejo C, Alain S, Galtier F, Foulongne V, Lagathu G, Lenzi N, Lesieur Z, Launay O, Jouneau S; FLUVAC Study Group. Sci Rep. 2022;12(1):4199.

18. Increased Incidence of Ventilator-Acquired Pneumonia in Coronavirus Disease 2019 Patients: A Multicentric Cohort Study. Vacheron CH, Lepape A, Savey A, Machut A, Timsit JF, Vanhems P, Le QV, Egbeola J, Martin M, Maxime V, Pugliesi PS, Maucort-Boulch D, Friggeri A; REA-REZO Study Group. Crit Care Med. 2022;50(3):449-459.

19. In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019: an observational study. Descamps A, Lenzi N, Galtier F, Lainé F, Lesieur Z, Vanhems P, Amour S, L'Honneur AS, Fidouh N, Foulongne V, Lagathu G, Duval X, Merle C, Lina B, Carrat F, Launay O, Loubet P; FLUVAC study group. Eur Respir J. 2022;59(3):2100651.

20. Nasopharyngeal Viral and Bacterial Co-Detection among Children from Low- and Middle-Income Countries with and without Pneumonia. Dananché C, Paranhos-Baccalà G, Messaoudi M, Sylla M, Awasthi S, Bavdekar A, Pape JW, Rouzier V, Wang J, Sanghavi S, Diallo S, Chou M, Eap T, Rakoto-Andrianarivelo M, Endtz H, Ren L, Dash-Yandag B, Guillen R, Nymadawa P, Russomando G, Komurian-Pradel F, Vanhems P, Picot VS; Pneumonia Global Approach for Biological Research, Infectious Diseases and Epidemics in Low-Income Countries (GABRIEL) Network. Am J Trop Med Hyg. 2022:tpmd210980.

21. COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhône-Alpes region (France): An ecological study. Romain-Scelle N, Elias C, Vanhems PVaccine. 2022;40(5):695-700.

22. COVID-19 outbreaks in nursing homes: A strong link with the coronavirus spread in the surrounding population, France, March to July 2020. Rabilloud M, Riche B, Etard JF, Elsensohn MH, Voirin N, Bénet T, Iwaz J, Ecochard R, Vanhems P. PLoS One. 2022;17(1):e0261756.

23. Baseline clinical features of COVID-19 patients, delay of hospital admission and clinical outcome: A complex relationship. Dananché C, Elias C, Hénaff L, Amour S, Kuczewski E, Gustin MP, Escuret V, Saadatian-Elahi M, Vanhems P. PLoS One. 2022;17(1):e0261428.

24. Venerable but Vulnerable: When Centenarians Encounter Coronavirus Disease 2019. Dessemon J, Elias C, Henaff L, Saadatian-Elahi M, Vanhems P. Open Forum Infect Dis. 2022;9(1):ofab580.

25. Vaccine effectiveness against COVID-19 hospitalization in adults in France: A test negative case control study. Luong Ngyen LB, Bauer R, Lesieur Z, Galtier F, Duval X, Vanhems P, Lainé F, Tattevin P, Durier C, Launay O; FLUVAC Study group. Infect Dis Now. 2022;52(1):40-43.

26. One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort. Loubet P, Wittkop L, Ninove L, Chalouni M, Barrou B, Blay JY, Hourmant M, Thouvenot E, Laville M, Laviolle B, Lelievre JD, Morel J, Quoc SN, Spano JP, Terrier B, Thiebaut A, Viallard JF, Vrtovsnik F, Circosta S, Esterle L, Levier A, Vanhems P, Tartour E, Parfait B, de Lamballerie X, Launay O; ANRS0001S COV-POPART study group. Clin Microbiol Infect. 2022 14: S1198-743X(22)00522-5.

 

Publications 2021

1. COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhône-Alpes region (France): An ecological study. Romain-Scelle N, Elias C, Vanhems PVaccine. 2021 Dec 22: S0264-410X(21)01644-3.

2. Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures. Pageaud S, Pothier C, Rigotti C, Eyraud-Loisel A, Bertoglio JP, Bienvenüe A, Leboisne N, Ponthus N, Gauchon R, Gueyffier F, Vanhems P, Iwaz J, Loisel S, Roy P, On Behalf Of The Group CovDyn Covid Dynamics. Vaccines (Basel). 2021 Dec 10;9(12):1462.

3. Vaccine effectiveness against COVID-19 hospitalization in adults in France: A test negative case control study. Luong Ngyen LB, Bauer R, Lesieur Z, Galtier F, Duval X, Vanhems P, Lainé F, Tattevin P, Durier C, Launay O; FLUVAC Study group. Infect Dis Now. 2021 Dec 15: S2666-9919(21)00547-9.

4. A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom. Rigoine de Fougerolles T, Puig-Barbera J, Kassianos G, Vanhems P, Schelling J, Crepey P, de Lejarazu RO, Ansaldi F, Fruhwein M, Galli C, Mosnier A, Pariani E, Rasuli A, Vitoux O, Watkins J, Weinke T, Bricout H. Influenza Other Respir Viruses. 2021 Dec 5. doi: 10.1111/irv.12941

5. External validation of the RISC, RISC-Malawi, and PERCH clinical prediction rules to identify risk of death in children hospitalized with pneumonia. Rees CA, Hooli S, King C, McCollum ED, Colbourn T, Lufesi N, Mwansambo C, Lazzerini M, Madhi SA, Cutland C, Nunes M, Gessner BD, Basnet S, Kartasasmita CB, Mathew JL, Zaman SMAU, Paranhos-Baccala G, Bhatnagar S, Wadhwa N, Lodha R, Aneja S, Santosham M, Picot VS, Sylla M, Awasthi S, Bavdekar A, Pape JW, Rouzier V, Chou M, Rakoto-Andrianarivelo M, Wang J, Nymadawa P, Vanhems P, Russomando G, Asghar R, Banajeh S, Iqbal I, MacLeod W, Maulen-Radovan I, Mino G, Saha S, Singhi S, Thea DM, Clara AW, Campbell H, Nair H, Falconer J, Williams LJ, Horne M, Strand T, Qazi SA, Nisar YB, Neuman MI; World Health Organization PREPARE study group48. J Glob Health. 2021;11:04062. doi: 10.7189/jogh.11.04062. eCollection 2021.

6. Psychological impact of an acute intervention on medical-psychological emergency unit professionals: the example of hurricane Irma. Razakarivony O, Khanafer N, Philippe JM, Prieto N. BJPsych Open. 2021;7(4):e113

7. The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19. Daou F, Abou-Sleymane G, Badro DA, Khanafer N, Tobaiqy M, Al Faraj A. Int J Environ Res Public Health. 2021;18(3):955

8. Experience from five Asia-Pacific countries during the first wave of the COVID-19 pandemic: Mitigation strategies and epidemiology outcomes. El Guerche-Séblain C, Chakir L, Nageshwaran G, Harris RC, Sevoz-Couche C, Vitoux O, Vanhems P. Travel Med Infect Dis. 2021;44:102171. doi: 10.1016/j.tmaid.2021.102171. 

9. Increased Incidence of Ventilator-Acquired Pneumonia in Coronavirus Disease 2019 Patients: A Multicentric Cohort Study. Vacheron CH, Lepape A, Savey A, Machut A, Timsit JF, Vanhems P, Le QV, Egbeola J, Martin M, Maxime V, Pugliesi PS, Maucort-Boulch D, Friggeri A; REA-REZO Study Group. Crit Care Med. 2021 doi:10.1097/CCM.0000000000005297.

10. Comparison of influenza surveillance systems in Australia, China, Malaysia and expert recommendations for influenza control. El Guerche-Séblain C, Rigoine De Fougerolles T, Sampson K, Jennings L, Van Buynder P, Shu Y, Sekawi Z, Yee-Sin L, Walls T, Vitoux O, Yin JK, Wong A, Schellevis F, Vanhems P. BMC Public Health. 2021;21(1):1750.

11. Incidence of hospital-acquired influenza in adults: A prospective surveillance study from 2004 to 2017 in a French tertiary care hospital. El Guerche-Séblain C, Amour S, Bénet T, Hénaff L, Escuret V, Schellevis F, Vanhems P. Am J Infect Control. 2021;49(8):1066-1071.

12. In-hospital and midterm out-hospital complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019: an observational study. Descamps A, Lenzi N, Galtier F, Lainé F, Lesieur Z, Vanhems P, Amour S, L'Honneur AS, Fidouh N, Foulongne V, Lagathu G, Duval X, Merle C, Lina B, Carrat F, Launay O, Loubet P; FLUVAC study group. Eur Respir J. 2021:2100651.

13. Association between mortality and highly antimicrobial-resistant bacteria in intensive care unit-acquired pneumonia. Lakbar I, Medam S, Ronflé R, Cassir N, Delamarre L, Hammad E, Lopez A, Lepape A, Machut A, Boucekine M, Zieleskiewicz L, Baumstarck K, Savey A, Leone M; REA RAISIN Study Group. Sci Rep. 2021;11(1):16497.

14. Tobacco smoking and severity of COVID-19: Experience from a hospital-based prospective cohort study in Lyon-France. Saadatian-Elahi M, Amour S, Elias C, Henaff L, Dananché C, Vanhems P. J Med Virol. 2021 :10.1002/jmv.27233. 

15. Factors Associated with Clostridioides (Clostridium) Difficile Infection and Colonization: Ongoing Prospective Cohort Study in a French University Hospital. Khanafer N, Vanhems P, Bennia S, Martin-Gaujard G, Juillard L, Rimmelé T, Argaud L, Martin O, Huriaux L, Marcotte G, Hernu R, Floccard B, Cassier P, Group S. Int J Environ Res Public Health. 2021;18(14):7528. 

16. Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France. Casalegno JS, Ploin D, Cantais A, Masson E, Bard E, Valette M, Fanget R, Targe SC, Myar-Dury AF, Doret-Dion M, Massoud M, Queromes G, Vanhems P, Claris O, Butin M, Pillet S, Ader F, Bin S, Gaymard A, Lina B, Morfin F; VRS study group in Lyon, Javouhey E, Gillet Y. Euro Surveill. 2021;26(29). 

17. Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? Van Summeren J, Meijer A, Aspelund G, Casalegno JS, Erna G, Hoang U, Lina B; VRS study group in Lyon, de Lusignan S, Teirlinck AC, Thors V, Paget J. Euro Surveill. 2021;26(29). 

18. A breath of humanity in the era of Covid-19 vaccine. P. Vanhems. Vaccine. 2021; 39(28): 3649

19. Automated surveillance in French ICUs: is it feasible? Results from a survey in French ICUs participating in a surveillance network. Lepape A, Machut A, Gerbier-Colomban S, Kuczewski E, Rasigade JP, Timsit JF, Vanhems P, Wallet F, Savey A, Friggeri A; REA-REZO Group. J Hosp Infect. 2021; 115:1-4

20. Trends in the proportion of resistant bacteria involved in ventilator-associated pneumonia as the first hospital-acquired infection in intensive care units between 2003 and 2016 in Lyon, France. Teoli J, Amour S, Dananché C, Dauwalder O, Gerbier-Colomban S, Mauranne CC, Zorio V, Monard C, Arnal S, Friggeri A, Lepape A, Guerin C, Rimmelé T, Argaud L, Munier-Marion E, Gustin MP, Vanhems P. Am J Infect Control. 2021: S0196-6553(21)00273-X 

21. Prognostic factors of severe community-acquired staphylococcal pneumonia in France. Gillet Y, Tristan A, Rasigade JP, Saadatian-Elahi M, Bouchiat C, Bes M, Dumitrescu O, Leloire M, Dupieux C, Laurent F, Lina G, Etienne J, Vanhems P, Argaud L, Vandenesch F; PVL pneumonia study group. Eur Respir J. 2021:2004445

22. Mortality Following Clostridioides difficile Infection in Europe: A Retrospective Multicenter Case-Control Study. Czepiel J, Krutova M, Mizrahi A, Khanafer N, Enoch DA, Patyi M, Deptuła A, Agodi A, Nuvials X, Pituch H, Wójcik-Bugajska M, Filipczak-Bryniarska I, Brzozowski B, Krzanowski M, Konturek K, Fedewicz M, Michalak M, Monpierre L, Vanhems P, Gouliouris T, Jurczyszyn A, Goldman-Mazur S, Wultańska D, Kuijper EJ, Skupień J, Biesiada G, Garlicki A. Antibiotics (Basel). 2021;10(3):299

23.The COVID-19 pandemic is deepening the health crisis in South Kivu. Écochard R, Wimba P, Bengehya J, Bianga PK, Lugwarha S, Oyimangirwe M, Bazeboso JA, Tshilolo L, Longo-Mbenza B, Rabilloud M, Iwaz J, Étard JF, Vanhems P. Int J Infect Dis. 2021: S1201-9712(21)00261-7

24. Incubation period of COVID-19: a meta-analysis. Elias C, Sekri A, Leblanc P, Cucherat M, Vanhems P. Int J Infect Dis. 2021;104 :708-10

25. Establishment of a French surveillance system of Clostridiodes difficile infection: comparison of patient’s characteristics with other national and European data. Khanafer N, Hemmendinger A, Guery B, Vachee A, Rogues AM, Gravet A, Boutoille D, Vanjak D, Barbut F, Vanhems P. Anaerobes 2021; 69:102329

26. Factors associated with admission to intensive care units in COVID-19 patients in Lyon-France. Vanhems P, Gustin MP, Elias C, Hénaff L, Dananché C, Grisi B, Marion E, Khanafer N, Hilliquin D, Gardes S, Gerbier-Colomban S, Amour S, Kuczewski E, Escuret V, Lina B, Saadatian-Elahi M, COVID-Outcomes-HCL Consortium. PLoS One 2021;16(1):e0243709

27. Incidence of Asymptomatic and Symptomatic Influenza Among Healthcare Workers: A Multicenter Prospective Cohort Study. Bénet T, Amour S, Valette M, Saadatian-Elahi M, Aho-Glélé LS, Berthelot P, Denis MA, Grando J, Landelle C, Astruc K, Paris A, Pillet S, Lina B, Vanhems P; AFP Study Group. Clin Infect Dis. 2021;72(9):e311-e318

28. A conceptual discussion about the basic reproduction number of Severe Acute Respiratory Syndrome Coronavirus 2 in healthcare settings.Temime L, Gustin MP, Duval A, Buetti N, Crépey P, Guillemot D, Thiébaut R, Vanhems P, Zahar JR, Smith DRM, Opatowski L. Clin Infect Dis. 2021;72(1):141-143

29. Characteristics of human pneumovirus infection in adults hospitalized community-acquired influenza-like illness in France, 2012-2018: a retrospective observational study. Loubet P, Mathieu P, Lenzi N, Galtier F, Lainé F, Lesieur Z, Vanhems P, Duval X, Postil D, Amour S, Rogez S, Lagathu G, L’Honneur AS, Foulongne V, Houhou N, Lina B, Carrat F, Launay O; Fluvac study group. Clin Microbiol Infect. 2021;27(1):127.e1-127.e6